Exonhit Announces New Scientific Publications on the Use of SpliceArray™
News Oct 30, 2008
ExonHit Therapeutics S.A. announces the publication of five new key scientific articles based on the use of its owned designed microarrays, SpliceArray™.
“We are excited that the use of ExonHit's microarrays (SpliceArray™ family of products) manufactured on the Agilent Technologies’ and Affymetrix’s microarray platforms, plays an intergral role in these scientific publications. These publications underline the relevance of ExonHit’s approach”, declared Loic Maurel, C.E.O of ExonHit.
“SpliceArray™ can be considered a new standard and a remarkable discovery tool which represents the most complete method to measure the expression of the Human transcriptome, and more recently the Rat transcriptome, in all their diversity. These tools are used by major academic research centers in Europe and the USA as well as by many of the top-tier pharmaceutical and biotechnology companies worldwide. Additionally, ExonHit remains the largest user of these microarrays, particularly within our internal molecular diagnostic discovery programs.”
Rapid Test Helps with Administering the "Correct" DrugNews
In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE